SNDXSyndax Pharmaceuticals, Inc.

$16.99+15% 1Y

Is it growing?

Good

Growing: revenue growing +223% year on year and operating margin widening (+562.0 points).

2 good, 1 without data
Revenue trend+223% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +178% a year.

Margin direction+562.0 points operating

Trailing-twelve-month operating margin, -81.0% now against -643.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SNDX growing?

Revenue growth, 5-year rate
+178%

Revenue growth, 5-year rate

Years of annual history on file
12

Years of annual history on file · FY2014 to FY2025, as filed

Details›
Revenue FY2021
$140M
Revenue FY2022
$0
Revenue FY2023
$0
Revenue FY2024
$24M
Revenue FY2025
$172M

Annual income statements as filed with the SEC.